For more information call
+44 (0)844 736 9016
or email us here
Mawdsleys are delighted to be partnering with LogixX Pharma Ltd to distribute their contract and non contract products to hospitals, as of 1st July.
Michael Close, Chief Executive Officer at LogixX Pharma states “We are thrilled to be partnering with Mawdsleys to expand our distribution services to the NHS. Mawdsleys' proven experience in delivering a first-class service in delivery reliability, picking accuracy and local customer care will ensure the right patients get the right medicine at the right time."
Mawdsleys are delighted to be partnering with Cipla to distribute their contract and non contract products to hospitals from 1st June.
Guy’s and St Thomas’ NHS Foundation Trust in London was looking for efficiencies within its procurement function at Guy’s Hospital.
Hospitals in Wales can order Europharma lines from Mawdsleys in their normal way:
Mawdsleys are delighted to be the distribution route to the NHS for Reig Jofre’s CMU contract products.
Hospitals can now order Reig Jofre products from Mawdsleys Wholesale in their normal way:
B Braun has chosen Mawdsleys as one of their two distributors to hospitals in England and Wales.
Mawdsleys will be distributing Strides Pharma UK products to English hospitals as part of CMU contract
Tillomed Laboratories use Mawdsleys to bring their injectable products to market
Mawdsleys become exclusive distributor of Consilient's new generic Anagrelide.
Neon Healthcare have chosen Mawdsleys as their distributor to hospitals in England for their first CMU contract award.
At Mawdsleys we understand that you need to be preparing your plans for the Carter review under the Hospital Pharmacy Transformation Programme (HPTP), but you might need support and information to get started. We have been consulting with key individuals in hospitals about their Lord Carter plans for some time and have started to supply data such as order frequency reports and audit data to help hospital trusts start planning.
Innovative and ground-breaking developments have been made within oncology treatment, as the first ever licensed Gemcitabine infusion bags receive regulatory approval.
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating all
medicines and medical devices in the UK, by ensuring they are safe and that those manufacturing,
storing and distributing them are fit to do so. It is compulsory that all UK pharmaceutical manufacturers and distributors undergo a system of licensing and inspection to certify their products are safe, and ensure that they work in compliance with regulatory requirements.
As of 1st May 2016, Mawdsleys will become the sole distributor for all Ranbaxy contracted products into the hospital sector (as you are aware, currently hospitals purchase Ranbaxy products directly). All products are now listed on Mawdsleys Online. To ensure continuity of supply all products can still be ordered through Ranbaxy directly until the end of May.
The contract wave has come back around and we want to share the work load with all of our customers! At Mawdsleys we believe in working together with our customers to help keep your blood pressure down at this stressful time.
Mawdsleys have recently announced new appointments in the business which will strengthen further the procurement capacity and support the supply chain for hospital customers.
November 2014 saw the start of one of the largest CMU National Contract Waves.
Mawdsleys are delighted that Niki Hodges has joined the company from Walsall Healthcare NHS Trust.
Mawdsleys have been working hard with manufacturers to provide additional choice for hospitals through new distribution agreements.
Mawdsleys have been nominated by Glenmark to distribute their CMU contracted products in England.
As of 1st November 2014, Mawdsleys have been nominated by Chanelle Medical to distribute their CMU contracted products in England. These products are only available via Mawdsleys and one other wholesaler.
As of 1st November 2014, Mawdsleys have been nominated by Typharm to distribute their CMU contracted products in England. These products are only available via Mawdsleys as a wholesale route and direct with Typharm.
Mawdsleys have been nominated as an additional wholesaler by Sinclair IS to distribute their products in England. This has been in place since August 2014.
As of 1st November 2014, Mawdsleys have been nominated by Genesis Pharma to distribute their CMU contracted products in England. These products will only be available via Mawdsleys and one other wholesaler.
Mawdsleys Unlicensed Medicines will be present at the Neonatal and Paediatric Pharmacists Group annual exhibition and conference on 7th-9th November 2014 at the East Midlands Conference Centre in Nottingham.
Since 1st August 2014, the full range of Dr Reddy’s UK Ltd NHS contracted products has also been distributed via Mawdsleys to NHS hospitals within England, Scotland & Wales.
Mawdsleys are delighted to announce a new solus hospital distribution agreement with M&A Pharmachem.
Mawdsleys have recently sent all our hospital customers contract notification packs with all the details they need for the new CMU contracts which started on 1st March & 1st May. As one of the nominated wholesalers for these manufacturer contracts, Mawdsleys pride ourselves, at all times possible, on being in a full stock situation from day one of new contracts waves.
Mawdsleys were praised by The Portland Hospital, the leading private hospital for children, for their commitment to ensuring an urgent unlicensed medicine was delivered to them late in the evening.
Mawdsleys have appointed Steve Bolas as National Sales Manager (Secondary Care). Steve joins us from AAH and his role will be to build upon existing customer relationships, and develop the secondary care proposition as well as looking into new markets and sectors.
Helping ensure patients have access to the drugs they need, when they need them.
Select from the following Worldwide sites...×